Acquired Hemophilia A
Rare Disease·MeSH: Factor 8 deficiency, acquired
Prevalence
12.0 / 100K
Incidence
20.0 / 100K/yr
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Frequently asked questions
How many drugs are in development for Acquired Hemophilia A?
BioSniper tracks 2 drugs in development for Acquired Hemophilia A across 2 companies.
How many clinical trials target Acquired Hemophilia A?
There are 3 clinical trials targeting Acquired Hemophilia A tracked by BioSniper.
What is the prevalence of Acquired Hemophilia A?
The estimated prevalence of Acquired Hemophilia A is approximately 12.0 per 100,000 population.
Deep-dive into Acquired Hemophilia A
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis